Zobrazeno 1 - 10
of 6 702
pro vyhledávání: '"PANITUMUMAB"'
Autor:
Latour CD; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Su IH; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Delgado M; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Pate V; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Poole C; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Edwards JK; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Stürmer T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Funk MJ; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e5885.
Autor:
Ballhausen A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin. Electronic address: alexej.ballhausen@charite.de., Karthaus M; Klinikum Neuperlach/Klinikum Harlaching, Department of Hematology, Oncology, and Palliative Care, Munich., Fruehauf S; Klinik Dr. Hancken GmbH, Department of Hematology, Oncology, and Palliative Care, Stade., Graeven U; Kliniken Maria Hilf GmbH, Department of Hematology, Oncology, and Gastroenterology, Mönchengladbach., Müller L; Oncological Practice UnterEms, Leer., König AO; Department of Gastroenterology and Gastrointestinal Oncology Göttingen, Göttingen., von Weikersthal LF; Gesundheitszentrum St. Marien, Amberg., Sommerhäuser G; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Jelas I; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Alig AHS; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Kurreck A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Stahler A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Goekkurt E; Practice of Hematology and Oncology (HOPE), Hamburg., Held S; ClinAssess GmbH, Leverkusen., Kasper S; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen., Heinrich K; University Hospital, LMU Munich, Department of Medicine III, Munich; Comprehensive Cancer Center Munich, Munich., Heinemann V; University Hospital, LMU Munich, Department of Medicine III, Munich; Comprehensive Cancer Center Munich, Munich; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg., Stintzing S; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg., Trarbach T; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen; Reha-Zentrum am Meer, Bad Zwischenahn, Germany., Modest DP; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
Publikováno v:
ESMO open [ESMO Open] 2024 Jul; Vol. 9 (7), pp. 103628. Date of Electronic Publication: 2024 Jul 13.
Autor:
Pataky RE; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada. Electronic address: rpataky@bccrc.ca., Weymann D; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., Bosdet I; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Cancer Genetics & Genomics Laboratory, BC Cancer, Vancouver, BC, Canada., Yip S; Cancer Genetics & Genomics Laboratory, BC Cancer, Vancouver, BC, Canada; Department of Pathology, BC Cancer, Vancouver, BC, Canada., Bryan S; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada., Sadatsafavi M; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Peacock S; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada; Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada., Regier DA; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Journal of cancer policy [J Cancer Policy] 2024 Sep; Vol. 41, pp. 100496. Date of Electronic Publication: 2024 Jul 18.
Autor:
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Geurts BS; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zeverijn LJ; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Wit GF; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Kusters B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Beerepoot LV; Department of Internal Medicine, ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands., Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Development Biology, Maastricht University Center+, Maastricht, The Netherlands., Buter J; Department of Medical Oncology, Amsterdam University Medical Center, Location VuMC, Amsterdam, The Netherlands., Gelderblom HAJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Voest EE; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam,The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 431-440.
Autor:
Bikbov MM; Ufa Eye Research Institute, Ufa, Russian Federation., Kazakbaeva GM; Ufa Eye Research Institute, Ufa, Russian Federation., Holz FG; Department of Ophthalmology, Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Germany., Panda-Jonas S; Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Mannheim, Germany., Gilemzianova LI; Ufa Eye Research Institute, Ufa, Russian Federation., Khakimov DA; Ufa Eye Research Institute, Ufa, Russian Federation., Jonas JB; Department of Ophthalmology, Heidelberg University, Heidelberg, Germany jost.jonas@medma.uni-heidelberg.de.
Publikováno v:
The British journal of ophthalmology [Br J Ophthalmol] 2024 May 21; Vol. 108 (6), pp. 859-864. Date of Electronic Publication: 2024 May 21.
Autor:
Taboada Paz L; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Vicente Basanta E; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Monteagudo Sánchez B; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
Publikováno v:
JAMA dermatology [JAMA Dermatol] 2024 Jun 01; Vol. 160 (6), pp. 667.
Autor:
Kluger N; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: nicolas.kluger@hus.fi., Jokela S; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Tolkki L; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Publikováno v:
Annales de dermatologie et de venereologie [Ann Dermatol Venereol] 2024 Jun; Vol. 151 (2), pp. 103271. Date of Electronic Publication: 2024 Apr 27.
Autor:
Zhan Y; Rudong People's Hospital / Affiliated Rudong Hospital of Xinglin College, Nantong University, Nantong, Jiangsu, 226400, China. 220110222844@email.sntcm.edu.cn., Cheng X; Ankang Hospital of Traditional Chinese Medicine, Ankang, Shaanxi, 725000, China., Mei P; Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China., Tan S; Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China., Feng W; Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China. 383686199@qq.com., Jiang H; Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jul 24; Vol. 24 (1), pp. 893. Date of Electronic Publication: 2024 Jul 24.
Autor:
Salgado Fernández M; Medical Oncology Service, Complejo Hospitalario Universitario de Ourense, Ramon Puga Noguerol Street, 54, 32005, Ourense, Spain. Mercedes.Salgado.Fernandez@sergas.es., Reboredo López M; Medical Oncology Service, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Covela Rúa M; Medical Oncology Service, Hospital Universitario Lucus Augusti, Lugo, Spain., Candamio S; Medical Oncology Service, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., González-Villarroel P; Medical Oncology Service, Hospital Álvaro Cunqueiro, Vigo, Spain., Sánchez-Cousido LF; Medical Oncology Service, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain., Graña B; Medical Oncology Service, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Carral-Maseda A; Medical Oncology Service, Hospital Universitario Lucus Augusti, Lugo, Spain., Cameselle-García S; Medical Oncology Service, Complejo Hospitalario Universitario de Ourense, Ramon Puga Noguerol Street, 54, 32005, Ourense, Spain., Varela Pose V; Medical Oncology Service, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Gallardo-Martín ME; Medical Oncology Service, Hospital Álvaro Cunqueiro, Vigo, Spain., Martínez-Lago N; Medical Oncology Service, Complexo Hospitalario Universitario de Ferrol, A Coruña, Spain.
Publikováno v:
Targeted oncology [Target Oncol] 2024 Jul; Vol. 19 (4), pp. 565-573. Date of Electronic Publication: 2024 May 23.
Autor:
Naemi AA; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Electronic address: parinaznaemi@gmail.com., Salmanian AH; Department of Agricultural Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran. Electronic address: salman@nigeb.ac.ir., Noormohammadi Z; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. Electronic address: z-nouri@srbiau.ac.ir., Amani J; Department of Molecular Biology, Green Gene Company, Tehran, Iran. Electronic address: Jafar.amani@gmail.com.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2023 Sep 15; Vol. 955, pp. 175894. Date of Electronic Publication: 2023 Jul 08.